Alembic Pharma planning to raise fund via NCDs
Alembic Pharmaceuticals is planning to raise funds on Private Placement Basis through issuance of Non-Convertible Debentures (NCDs). The Board of Directors of the Company at its meeting to be held on December 06, 2018 to consider the same.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.